Learn More About Plantar Fibromatosis and
How Transdermal Verapamil 15% Gel Can Help

Clinical Data

PDLabs is currently sponsoring a study specific to plantar fibromatosis. This is a two site, open label study to determine the ability of Transdermal Verapamil 15% Gel to reduce pain and the size of the lesion(s). This is an on going study due to the relatively small patient population; however, substantial reduction in pain and lesion size has been seen suggesting the likelihood of a positive outcome. The graphs below summarize the interim results of the study.graphs showing clinical study resultsgraphs showing clinical study results